Halozyme Therapeutics Inc (HALO)
37.96
+0.15
(+0.40%)
USD |
NASDAQ |
Apr 19, 14:48
Halozyme Therapeutics Cash and Short Term Investments (Quarterly): 336.00M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 336.00M |
| September 30, 2023 | 483.28M |
| June 30, 2023 | 348.28M |
| March 31, 2023 | 275.61M |
| December 31, 2022 | 362.79M |
| September 30, 2022 | 265.58M |
| June 30, 2022 | 209.36M |
| March 31, 2022 | 786.14M |
| December 31, 2021 | 740.92M |
| September 30, 2021 | 815.92M |
| June 30, 2021 | 755.31M |
| March 31, 2021 | 764.31M |
| December 31, 2020 | 368.01M |
| September 30, 2020 | 346.71M |
| June 30, 2020 | 385.45M |
| March 31, 2020 | 368.18M |
| December 31, 2019 | 421.26M |
| September 30, 2019 | 238.00M |
| June 30, 2019 | 287.46M |
| March 31, 2019 | 328.72M |
| December 31, 2018 | 354.53M |
| September 30, 2018 | 364.37M |
| June 30, 2018 | 398.89M |
| March 31, 2018 | 433.69M |
| December 31, 2017 | 469.21M |
| Date | Value |
|---|---|
| September 30, 2017 | 316.92M |
| June 30, 2017 | 297.53M |
| March 31, 2017 | 178.98M |
| December 31, 2016 | 204.98M |
| September 30, 2016 | 221.05M |
| June 30, 2016 | 229.99M |
| March 31, 2016 | 238.64M |
| December 31, 2015 | 108.34M |
| September 30, 2015 | 123.72M |
| June 30, 2015 | 140.72M |
| March 31, 2015 | 128.50M |
| December 31, 2014 | 135.62M |
| September 30, 2014 | 134.46M |
| June 30, 2014 | 147.65M |
| March 31, 2014 | 164.49M |
| December 31, 2013 | 71.50M |
| September 30, 2013 | 65.31M |
| June 30, 2013 | 76.01M |
| March 31, 2013 | 87.43M |
| December 31, 2012 | 99.50M |
| September 30, 2012 | 87.61M |
| June 30, 2012 | 102.04M |
| March 31, 2012 | 116.61M |
| December 31, 2011 | 52.83M |
| September 30, 2011 | 66.33M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
209.36M
Minimum
Jun 2022
815.92M
Maximum
Sep 2021
450.45M
Average
368.01M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Johnson & Johnson | 22.93B |
| Globus Medical Inc | 517.79M |
| Denali Therapeutics Inc | 1.035B |
| AIM ImmunoTech Inc | 13.07M |
| Protalix BioTherapeutics Inc | 44.56M |